Profile picture

Professor Javier Jimenez-Candil

IBSAL-Hospital Universitario de Salamanca, Salamanca (Spain)
Membership: EHRA Member
Follow
Biography
Head of the Arrhythmias and Electrophysiology Unit of the University Hospital of Salamanca. Associate Professor of the Department of Medicine of the University of Salamanca. Past President of the Electrophysiology and Arrhythmias Working Group of the Spanish Society of Cardiology.
Logo ESC

Contributor content

Outpatient atrial fibrillation ablation: feasibility, safety and economic implications
Presentation
Outpatient atrial fibrillation ablation: feasibility, safety and economic implications
Relationship between episodes of unsustained VTs detected early after an ICD implant and subsequent monomorphic VTs causing appropriate therapy.
Presentation
Relationship between episodes of unsustained VTs detected early after an ICD implant and subsequent monomorphic VTs causing appropriate therapy.
Effectiveness of first versus subsequentes ATP attemps: predictors and clinical consequences
Presentation
Effectiveness of first versus subsequentes ATP attemps: predictors and clinical consequences
Predictors of Electrical Strom among ICD patients: the importance of the burden of non-sustained VTs
Presentation
Predictors of Electrical Strom among ICD patients: the importance of the burden of non-sustained VTs
Antitachycardia pacing for slow VTs: efficacy and safety after a first unsuccessful attempt.
Presentation
Antitachycardia pacing for slow VTs: efficacy and safety after a first unsuccessful attempt.
Burden of non-sustained ventricular tachycardias occurring early after an ICD implant: long-term effect on the electrical therapies due to Monomorphic Ventricular Tachycardias.
Presentation
Burden of non-sustained ventricular tachycardias occurring early after an ICD implant: long-term effect on the electrical therapies due to Monomorphic Ventricular Tachycardias.
Reduction of fast-VT related syncope by beta-blockers: a dose-dependent effect. Results from a multicenter study.
Presentation
Reduction of fast-VT related syncope by beta-blockers: a dose-dependent effect. Results from a multicenter study.
Influence of beta-blocker therapy on the incidence and on the timing of heart failure decompensation after an ICD shock.
Presentation
Influence of beta-blocker therapy on the incidence and on the timing of heart failure decompensation after an ICD shock.
Beta-blockers reduce fast VT-related syncope through a dose-dependent effect. Results from a multicenter study.
Presentation
Beta-blockers reduce fast VT-related syncope through a dose-dependent effect. Results from a multicenter study.
Incidence and timing of heart failure decompensation after the first ICD shock: the influence of beta-blocker therapy.
Presentation
Incidence and timing of heart failure decompensation after the first ICD shock: the influence of beta-blocker therapy.

ESC 365 is supported by